Harel Insurance Investments & Financial Services Ltd. / TEVA
Harel Insurance Investments & Financial Services Ltd.’s Teva Pharmaceutical Inds Ltd Position
Does Harel Insurance Investments & Financial Services Ltd. own Teva Pharmaceutical Inds Ltd (TEVA)? Yes — 45.96M shares worth $1.4B (+9.39% of its 13F portfolio) as of Q1 2026, up from 44.95M shares the prior filed quarter.
Position Value
$1.4B
Q1 2026
Shares
45.96M
% of Portfolio
+9.39%
Quarters Held
29
currently held
Position History TEVA
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 45.96M | $1.4B | +9.39% |
| Q4 2025 | 44.95M | $1.4B | +12.15% |
| Q3 2025 | 37.70M | $761M | +6.84% |
| Q2 2025 | 33.39M | $560M | +6.40% |
| Q1 2025 | 22.06M | $339M | +4.44% |
| Q4 2024 | 11.1K | $246,000 | 0.00% |
| Q3 2024 | 19.7K | $355,000 | +0.01% |
| Q2 2024 | 19.2K | $312,000 | +0.01% |
| Q1 2024 | 25.8K | $363,000 | +0.01% |
| Q4 2023 | 28.53M | $298M | +5.24% |
| Q3 2023 | 27.71M | $283M | +5.58% |
| Q2 2023 | 15.0K | $114,000 | 0.00% |
| Q1 2023 | 23.30M | $206M | +4.23% |
| Q4 2022 | 15.12M | $138M | +3.03% |
| Q3 2022 | 14.13M | $114M | +2.79% |
| Q2 2022 | 11.45M | $86M | +1.81% |
| Q1 2022 | 10.48M | $98M | +1.61% |
| Q4 2021 | 9.94M | $80M | +1.50% |
| Q3 2021 | 10.04M | $98M | +2.54% |
| Q2 2021 | 9.94M | $99M | +2.17% |
| Q1 2021 | 9.96M | $116M | +2.18% |
| Q4 2020 | 9.30M | $90M | +2.13% |
| Q3 2020 | 8.09M | $73M | +2.48% |
| Q2 2020 | 7.62M | $94M | +3.23% |
| Q1 2020 | 6.53M | $59M | +2.75% |
| Q4 2019 | 5.35M | $52M | +2.28% |
| Q2 2019 | 5.35M | $49M | +2.64% |
| Q1 2019 | 5.32M | $83M | +4.86% |
| Q4 2018 | 5.72M | $88M | +5.41% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Harel Insurance Investments & Financial Services Ltd.’s full portfolio or all institutional holders of TEVA.